HIV-associated cardiomyopathy;HIV-bedingte Kardiomyopathie

Herz

Volumn 30, Issue 6, 2005, Pages 545-549

  Neumann, Till ^a   Kondratieva, Jana ^a   Breuckmann, Frank ^a   Erbel, Raimund ^a,b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

AIDS; Cardiomyopathy; HAART; HIV infection

Indexed keywords

ALPHA INTERFERON; AMPHOTERICIN B; ANTIRETROVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COCAINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXORUBICIN; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERFERON; INTERLEUKIN 2; ZIDOVUDINE;

ADENOVIRUS; ARTICLE; AWARENESS; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; COXSACKIE VIRUS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EXPECTATION; FREQUENCY ANALYSIS; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE INJURY; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MITOCHONDRIAL TOXICITY; MORBIDITY; MORTALITY; NONHODGKIN LYMPHOMA; NONHUMAN; PARVOVIRUS; PATHOGENESIS; POPULATION; PREDICTION; PROGNOSIS; SCREENING; STANDARD; THROMBOEMBOLISM; TOXOPLASMA GONDII;

CARDIOMYOPATHIES; CLINICAL TRIALS; HIV INFECTIONS; HUMANS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 25444493353     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-005-2729-y     Document Type: Article

References (36)

1. World Health Organisation (UNAIDS). UNAIDS 2004. Report on the global AIDS epidemic. Geneva: WHO, 2005 (http://www.who.int/hiv/en/).
2. Robert-Koch-Institut. Eckdaten und Trends der HIV-Epidemie in Deutschland (Stand Ende 2004). Berlin: Robert-Koch-Institut, 2005 (http://www.rki.de).
3. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
4. Detels R, Munoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA 1998;280:1497-503.
5. Detels R, Tarwater P, Phair JP, et al. Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis. AIDS 2001;15:347-55.
6. Herowitz A. Cardiomyopathy and other symptomatic heart diseases associated with HIV infection. Curr Opin Cardiol 1996;111:325-31.
7. Cohen IS, Anderson DW, Virmani R, et al. Congestive cardiomyopathy in association with the acquired immunodeficiency syndrome. N Engl J Med 1986;315:628-30.
8. Corboy JR, Fink L, Miller WT. Congestive cardiomyopathy in association with AIDS. Radiology 1987;165:139-41.
9. De Palo VA, Millstein BH, Myo PH, et al. Outcome of intensive care in patients with HIV infection. Chest 1995;107:506-10.
10. Jacob AJ, Sutherland GR, Bird AG, et al. Myocardial dysfunction in patients infected with HIV: prevalence and risk factors. Br Heart J 1992;68:549-53.
11. Barbaro G, Klatt EC. HIV infection and the cardiovascular system. AIDS Rev 2002;4:93-103.
12. Chariot P, Perchet H, Monnet I. Dilated cardiomyopathy in HIV-infected patients [Letter]. N Engl J Med 1999;340:732.
13. Malnick S, Goland S. Dilated cardiomyopathy in HIV-infected patients [Letter]. N Engl J Med 1999;340:732-3.
14. Flotats A, Domingo P, Carrio I. Dilated cardiomyopathy in HIV-infected patients [Letter]. N Engl J Med 1999;340:733-4.
15. Barbaro G, Di Lorenzo G, Grisorio B, et al. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med 1998;339:1093-9.
16. Drazen JM, Curfman GD. Retraction: Barbaro et al. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients (N Engl J Med 1998;339:1093-9). N Engl J Med 2002;347:140.
17. Roy VP, Prabhakar S, Pulvirenti J, et al. Frequency and factors associated with cardiomyopathy in patients with human immunodeficiency virus infection in an inner-city hospital. J Natl Med Assoc 1999;91:502-4.
18. Barbaro G, Di Lorenzo G, Grisorio B, et al. Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS Investigators. AIDS Res 1998;14:1071-7.
19. Patel RC, Frishman WH. Cardiac involvement in HIV infection. Med Clin North Am 1996;80:1493-512.
20. Wu TC, Pizzorno MC, Hayward GS, et al. In situ detection of human cytomegalovirus immediate-early gene transcripts within cardiac myocytes of patients with HIV-associated cardiomyopathy. AIDS 1992;6:777-85.
21. Nosanchuk JD. Fungal myocarditis. Front Biosci 2002;1:d1423-38.
22. Barbaro G. Selenium deficiency and HIV-associated cardiomyopathy. J R Soc Med 2002;95:57
23. Currie PF, Goldman JH, Caforio ALP. Cardiac autoimmunity in HIV related heart muscle disease. Heart 1998;79:599-604.
24. Grody WW, Cheng L, Lewis W. Infection of the heart by the human immunodeficiency virus. Am J Cardiol 1990;66:203-6.
25. Chen F, Shannon K, Ding S, et al. HIV type 1 glycoprotein 120 inhibits cardiac myocyte contraction. AIDS Res Hum Retroviruses 2002;18:777-84.
26. Raidel SM, Haase C, Jansen NR, et al. Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage. Am J Physiol Heart Circ Physiol 2002;282:H1672-8.
27. Sundstrom JB, Mosunjac M, Martinson DE, et al. Effects of norepinephrine, HIV type 1 infection, and leukocyte interactions with endothelial cells on the expression of matrix metalloproteinases. AIDS Res Hum Retroviruses 2001;17:1605-14.
28. Lewis W, Grupp IL, Grupp G, et al. Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine. Lab Invest 2000;80:187-97.
29. Frerichs FC, Dingemans KP, Brinkman K. Cardiomyopathy with mitochondrial damage associated with nucleoside reverse transcriptase inhibitors. N Engl J Med 2002;347:1895-6.
30. Twu C, Liu NQ, Popik W, et al. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways. Proc Natl Acad Sci U S A 2002;99:14386-91.
31. Fingerhood M. Full recovery from severe dilated cardiomyopathy in an HIV-infected patient. AIDS Read 2001;11:333-5.
32. Tayal SC, Ghosh SK, Reaich D. Asymptomatic HIV patient with cardiomyopathy and nephropathy: case report and literature review. J Infect 2001;42:288-90.
33. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342:1077-84.
34. Lipshultz SE, Oray ED, Sanders SP, et al. Immunoglobulins and left ventricular structure and function in paediatrics HIV infection. Circulation 1995;92:220-5.
35. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-40.
36. Calabrese LH, Albrecht M, Young J, et al. Successful cardiac transplantation in an HIV-1-infected patient with advanced disease. N Engl J Med 2003;348:2323-8.